Literature DB >> 10229407

Requirement for total hip arthroplasty: an outcome measure of hip osteoarthritis?

M Dougados1, A Gueguen, M Nguyen, L Berdah, M Lequesne, B Mazieres, E Vignon.   

Abstract

OBJECTIVE: To assess if total hip arthroplasty (THA) is a valid outcome measure of hip osteoarthritis (OA), in respect to clinical and radiological assessments.
METHODS: A prospective 3 year study of patients who had painful hip OA with an initial radiographic joint space width > or =1 mm at the narrowest point. Dependent variable was THA. Patient data including body mass index, OA structural severity by radiograph, OA symptomatic severity (pain, function), and OA localization were recorded at entry. Pelvic radiographs were obtained before THA, when available, and once yearly during the study.
RESULTS: During the study 106 of 506 patients underwent THA. Risk was estimated (Kaplan-Meier method) to be 8+/-1, 16+/-2, and 23+/-2% after 1, 2, and 3 years, respectively. Factors predisposing to requirement for surgery were: age > or =70 years, female sex, superolateral migration of the femoral head, joint space width <2 mm, Kellgren-Lawrence grade > or =3, pain (visual analog scale) > or =50 mm, and Lequesne index > or =10 with a relative risk of 1.65, 1.71, 1.96, 1.85, 1.89, 1.86, and 2.59, respectively. Mean change in joint space width was 0.22+/-0.50 vs 0.97+/-1.35 mm/year in patients without and with THA, respectively (p<0.0001). Changes in radiological joint space width during the first year were highly predictive of requirement for THA during the 2 following years (risk of 5, 13, 25, and 79% in patients with a radiological joint space width worsening during the first year of 0, < or =25, >25 and < or =50, and >50%, respectively).
CONCLUSION: These data suggest that THA could be considered as a valid outcome measure in OA. However, further studies should be conducted in other countries with different health care systems to evaluate the inter-country reliability of this measurement.

Entities:  

Mesh:

Year:  1999        PMID: 10229407

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  18 in total

Review 1.  EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  W Zhang; M Doherty; N Arden; B Bannwarth; J Bijlsma; K-P Gunther; H J Hauselmann; G Herrero-Beaumont; K Jordan; P Kaklamanis; B Leeb; M Lequesne; S Lohmander; B Mazieres; E Martin-Mola; K Pavelka; A Pendleton; L Punzi; B Swoboda; R Varatojo; G Verbruggen; I Zimmermann-Gorska; M Dougados
Journal:  Ann Rheum Dis       Date:  2004-10-07       Impact factor: 19.103

2.  Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort.

Authors:  B Mazières; P Garnero; A Guéguen; M Abbal; L Berdah; M Lequesne; M Nguyen; J-P Salles; E Vignon; M Dougados
Journal:  Ann Rheum Dis       Date:  2005-12-01       Impact factor: 19.103

3.  The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement.

Authors:  L Gossec; S Paternotte; J F Maillefert; C Combescure; P G Conaghan; A M Davis; K-P Gunther; G Hawker; M Hochberg; J N Katz; M Kloppenburg; K Lim; L S Lohmander; N N Mahomed; L March; K Pavelka; L Punzi; E M Roos; L Sanchez-Riera; J A Singh; M E Suarez-Almazor; M Dougados
Journal:  Osteoarthritis Cartilage       Date:  2010-10-31       Impact factor: 6.576

Review 4.  How can one develop disease-modifying drugs in osteoarthritis?

Authors:  Maxime Dougados
Journal:  Curr Rheumatol Rep       Date:  2005-03       Impact factor: 4.592

5.  Increased body mass index is a predisposition for treatment by total hip replacement.

Authors:  Steffen Jacobsen; Stig Sonne-Holm
Journal:  Int Orthop       Date:  2005-04-26       Impact factor: 3.075

6.  Role of radiography in predicting progression of osteoarthritis of the hip: prospective cohort study.

Authors:  Max Reijman; J M W Hazes; H A P Pols; R M D Bernsen; B W Koes; S M A Bierma-Zeinstra
Journal:  BMJ       Date:  2005-05-13

Review 7.  OARSI Clinical Trials Recommendations: Hip imaging in clinical trials in osteoarthritis.

Authors:  G E Gold; F Cicuttini; M D Crema; F Eckstein; A Guermazi; R Kijowski; T M Link; E Maheu; J Martel-Pelletier; C G Miller; J-P Pelletier; C G Peterfy; H G Potter; F W Roemer; D J Hunter
Journal:  Osteoarthritis Cartilage       Date:  2015-05       Impact factor: 6.576

8.  Sex differences in hip osteoarthritis: results of a longitudinal study in 508 patients.

Authors:  J F Maillefert; A Gueguen; M Monreal; M Nguyen; L Berdah; M Lequesne; B Mazieres; E Vignon; M Dougados
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

9.  Hip pain and mobility deficits--hip osteoarthritis: clinical practice guidelines linked to the international classification of functioning, disability, and health from the orthopaedic section of the American Physical Therapy Association.

Authors:  Michael T Cibulka; Douglas M White; Judith Woehrle; Marcie Harris-Hayes; Keelan Enseki; Timothy L Fagerson; James Slover; Joseph J Godges
Journal:  J Orthop Sports Phys Ther       Date:  2009-04       Impact factor: 4.751

10.  Validity and reliability of three definitions of hip osteoarthritis: cross sectional and longitudinal approach.

Authors:  M Reijman; J M W Hazes; H A P Pols; R M D Bernsen; B W Koes; S M A Bierma-Zeinstra
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.